| Literature DB >> 33023057 |
Galina Guseva1, Elena Antina1, Mikhail Berezin1, Svetlana Lisovskaya2,3, Roman Pavelyev4, Airat Kayumov4, Olga Lodochnikova4,5, Daut Islamov4,5, Konstantin Usachev4, Sergei Boichuk2, Liliya Nikitina2,4.
Abstract
This study focuses on the behavior of a new fluorescent marker for labeling individual biomolecules and staining cell organelles developed on a meso-substituted BODIPY platform. Boron(III) complex with meso-4-methoxycarbonylpropylsubstituted 3,3',5,5'-tetramethyl-2,2'-dipyrromethene has been synthesized and identified via visible, UV-, NMR- and MS-spectra X-ray. The behavior of fluorophore in solutions has been studied with various experimental techniques. It has been found that luminophore exhibits a high quantum yield (almost ~100-75%) in the blue-green region (513-520 nm) and has high photostability. In addition, biological analysis indicates that the fluorophore exhibits a tendency to effectively penetrate into cell membranes. On the other hand, the proposed BODIPY can be used to study the significant differences among a large number of pathogens of mycotic infections, as well as to visualize structural changes in the plasma membrane, which is necessary for the clearance of mammalian cells undergoing apoptotic cell death.Entities:
Keywords: BODIPY; biomarker; dipyrromethene; fluorophore; pathogenic microorganisms
Mesh:
Substances:
Year: 2020 PMID: 33023057 PMCID: PMC7582871 DOI: 10.3390/molecules25194541
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1The synthesis scheme of [BF2L].
Figure 2Normalized electronic absorption and emission spectra of [BF2L] solution in organic solvents.
The spectroscopic characteristics of [BF2L] in organic solvents 1.
| Solvent | Δ | ||||||
|---|---|---|---|---|---|---|---|
|
| 502 (72,772) | 516 | 541 | 1.000 | 8.33 | 0 | 12.0 |
|
| 503(70,323) | 520 | 650 | 0.979 | 6.83 | 0.14 | 14.3 |
|
| 502(66,317) | 517 | 578 | 0.972 | 6.84 | 0.20 | 14.2 |
|
| 502(61,467) | 516 | 541 | 0.969 | 6.06 | 0.19 | 16.0 |
|
| 499(59,849) | 514 | 585 | 0.949 | 6.30 | 0.34 | 15.1 |
|
| 498(60,491) | 513 | 587 | 0.799 | 6.39 | 1.61 | 12.5 |
|
| 498(56,469) | 515 | 663 | 0.749 | 5.96 | 2.02 | 12.6 |
1λ, λex, λ— absorption, excitation and fluorescence maxima respectively, nm; sh—shoulder; ε—molar absorption coefficient (L·mol−1·cm−1); Δνst—Stokes shift, cm−1; φ—fluorescence quantum yield; krad, kr—rate constants of radiative process and nonradiative deactivation respectively, s–1; τ—fluorescence lifetime, ns.
Quantitative characteristics of BODIPYs photostability in organic solvents.
| Complexes | Solvent | ||
|---|---|---|---|
| cyclohexane | 46.0 | 3.3 ± 0.1 | |
|
| cyclohexane | 88.6 | 2.9 ± 0.2 |
Figure 3The changes of the electronic absorption (a) and fluorescence (b) spectra of a [BF2L] solution in toluene under UV irradiation.
Figure 4CLSM of fungal cells of C. albicans and F. oxysporum. The scale bar is 5 microns. Photos (a,b)—cells of C. albicans fungi (after 10–30 min staining with [BF2L], intensely stained nuclei and membranes of the structural components of the cell are visible. Photo (c)—hyphal, multinucleated fungus F. Oxysporum cells (after 30 min staining with [BF2L] intensely stained nuclei and membranes of the structural components of the cell are visible). Photo (d)—hyphae of the fungus F. Oxysporum (unpainted preparation).
Figure 5Changes in [BF2L]-mediated fluorescence as a potential marker of reorganization of Table 1. R cancer cells (lower panel) pretreated with doxorubicin (0.5 µg/mL) for 24 h or left untreated (control) prior to the [BF2L] exposure (1 h). The experiments were performed in triplicates. The images were shown at 40x and 100x magnifications for each experimental condition.
Figure 6Subcellular distribution of [BF2L] (green) co-stained with MitoTracker® Red CMXRos (red) in GIST T-1R cancer cells. Cells were stained with DAPI (blue) to outline the nucleus. The experiments were performed in the triplicates. The images were shown at 20x (a) and 100x (b) magnifications.